BioPharmSignal logoBioPharmSignal

Biotech News

Progyny, Inc. Announces Share Repurchase Program

Progyny (PGNY)ProgynyCompany update

NEW YORK, May 26, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announced that its Board of Directors has approved a share repurchase program to repurchase up to $200 million of its common stock.

Open original release

Related news

PGNYProgyny2026-05-28 13:04 EST

New Progyny Study Shows Growing Demand for Human Guidance in an Increasingly Digital Healthcare System

PGNYProgyny2026-05-11 14:57 EST

Progyny, Inc. to Present at BofA Securities 2026 Health Care Conference

HSTMHealthStream2026-03-13 20:05 EST

HealthStream Announces Share Repurchase Program

COOThe Cooper Companies2025-09-17 20:15 EST

CooperCompanies Announces Expanded Share Repurchase Program

View all latest news

Progyny

Progyny is a fertility and family-building benefits company serving employers and their members through specialized reproductive-health services.

Recent company news

PGNYProgyny2026-05-28 13:04 EST

New Progyny Study Shows Growing Demand for Human Guidance in an Increasingly Digital Healthcare System

PGNYProgyny2026-05-26 12:00 EST

Progyny, Inc. Announces Share Repurchase Program

PGNYProgyny2026-05-11 14:57 EST

Progyny, Inc. to Present at BofA Securities 2026 Health Care Conference

PGNYProgyny2026-05-07 20:01 EST

Progyny, Inc. Announces First Quarter 2026 Results

PGNYProgyny2026-04-23 17:56 EST

Progyny, Inc. Announces Details for Its First Quarter 2026 Results Report

Stock data

Close
31.59 USD
Market cap
1.97B USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States